Virtus Fund Advisers’s Charles River Laboratories CRL Stock Holding History

Virtus Fund Advisers’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-169	Closed	-$14K	–	579
2015 Q4	$14K	Hold	169	–	–	﹤0.01%	574
2015 Q3	$11K	Hold	169	–	–	﹤0.01%	599
2015 Q2	$12K	Sell	169 -782	-82%	-$57.9K	﹤0.01%	615
2015 Q1	$75K	Sell	951 -94	-9%	-$6.93K	﹤0.01%	613
2014 Q4	$67K	Hold	1,045	–	–	﹤0.01%	707
2014 Q3	$62K	Sell	1,045 -5,062	-83%	-$290K	﹤0.01%	742
2014 Q2	$327K	Buy	+6,107	New	+$335K	﹤0.01%	813

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Virtus Fund Advisers's CRL Position: Q1 2016 in Review

Virtus Fund Advisers sold out of Charles River Laboratories (CRL) in Q1 2016, closing a stake of 169 shares — an estimated $14K sold.

Virtus Fund Advisers first reported a position in CRL in Q2 2014 and held it in 7 quarters. The position peaked at $327K in Q2 2014. 264 funds tracked by Wall St. Rank hold CRL as of Q1 2016.

Virtus Fund Advisers reported no remaining Charles River Laboratories position as of Q1 2016 after selling out during the quarter.
Virtus Fund Advisers sold 169 Charles River Laboratories shares in Q1 2016, an estimated $14K.
Virtus Fund Advisers first reported a position in Charles River Laboratories in Q2 2014 and held it in 7 quarters.
Virtus Fund Advisers's Charles River Laboratories position peaked at $327K in Q2 2014.
264 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2016.

Based on Virtus Fund Advisers's 13F filing for Q1 2016, filed 11 May 2016.